Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Axthelm Michael K."" wg kryterium: Autor


Tytuł:
Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis.
Autorzy:
Plumlee, Courtney R.
Duffy, Fergal J.
Gern, Benjamin H.
Delahaye, Jared L.
Cohen, Sara B.
Stoltzfus, Caleb R.
Rustad, Tige R.
Hansen, Scott G.
Axthelm, Michael K.
Picker, Louis J.
Aitchison, John D.
Sherman, David R.
Ganusov, Vitaly V.
Gerner, Michael Y.
Zak, Daniel E.
Urdahl, Kevin B.
Pokaż więcej
Źródło:
Cell Host & Microbe; Jan2021, Vol. 29 Issue 1, p68-68, 1p
Czasopismo naukowe
Tytuł:
Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model.
Autorzy:
Gravett, Michael G.
Adams, Kristina M.
Sadowsky, Drew W.
Grosvenor, Alexandra R.
Witkin, Steven S.
Axthelm, Michael K.
Novy, Miles J.
Pokaż więcej
Temat:
PREMATURE labor
INDOMETHACIN
ANTIARTHRITIC agents
STREPTOCOCCUS
PREGNANCY complications
INFLAMMATORY mediators
Źródło:
American Journal of Obstetrics & Gynecology; Nov2007, Vol. 197 Issue 5, p518-518, 1p
Czasopismo naukowe
Tytuł:
Mayaro virus pathogenesis and immunity in rhesus macaques.
Autorzy:
Weber WC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America.
Labriola CS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Ray K; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Haese NN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Andoh TF; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Denton M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Medica S; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America.
Streblow MM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Smith PP; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Mizuno N; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Frias N; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Fisher MB; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Barber-Axthelm AM; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Chun K; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Uttke S; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Whitcomb D; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
DeFilippis V; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Rakshe S; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Fei SS; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Smedley JV; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Nov 20; Vol. 17 (11), pp. e0011742. Date of Electronic Publication: 2023 Nov 20 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Alphavirus*
Chikungunya virus*
Alphavirus Infections*
Animals ; Mice ; Male ; Macaca mulatta ; Viremia ; Mice, Inbred C57BL ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis.
Autorzy:
Moats C; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Cook K; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Armantrout K; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Crank H; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Uttke S; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Maher K; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Bochart RM; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Lawrence G; Director's Office, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Axthelm MK; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Smedley JV; Infectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Apr 20; Vol. 17 (4), pp. e0266616. Date of Electronic Publication: 2022 Apr 20 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-Infective Agents*/therapeutic use
HIV-1*
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Immunodeficiency Virus*
Animals ; Anti-Bacterial Agents/therapeutic use ; Macaca fascicularis ; Macaca mulatta ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
Autorzy:
Barrenäs F; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Law L; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Driscoll C; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Green RR; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Smith E; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Chang J; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Golez I; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Urion T; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Peng X; Department of Molecular Biomedical Sciences and Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, United States of America.
Whitmore L; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Newhouse D; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Randall KT; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Randall BE; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Oswald K; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
Shoemaker R; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
Fast R; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
Bosche WJ; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Fukazawa Y; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Pavlakis GN; Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
Fourati S; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
Lifson JD; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
Komorowski J; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Kosmider E; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Shao D; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Song W; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2021 Jul 06; Vol. 17 (7), pp. e1009278. Date of Electronic Publication: 2021 Jul 06 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
CD8-Positive T-Lymphocytes/*immunology
Interleukin-15/*immunology
SAIDS Vaccines/*immunology
Simian Immunodeficiency Virus/*immunology
Animals ; Cytomegalovirus ; Female ; Genetic Vectors ; Macaca mulatta ; Male ; Simian Acquired Immunodeficiency Syndrome/prevention & control
Czasopismo naukowe
Tytuł:
Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
Autorzy:
Bochart RM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Busman-Sahay K; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Bondoc S; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Morrow DW; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Ortiz AM; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.
Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Fischer MB; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Shiel O; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Swanson T; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Shriver-Munsch CM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Crank HB; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Armantrout KM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Barber-Axthelm AM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Langner C; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.
Moats CR; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Labriola CS; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
MacAllister R; Division of Comparative Medicine, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Axthelm MK; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Brenchley JM; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.
Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Estes JD; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Hansen SG; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Smedley JV; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2021 May 10; Vol. 17 (5), pp. e1009565. Date of Electronic Publication: 2021 May 10 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Inflammation/*therapy
Microbiota/*drug effects
Simian Acquired Immunodeficiency Syndrome/*therapy
Simian Immunodeficiency Virus/*immunology
Adaptive Immunity ; Animals ; B-Lymphocytes ; CD4-Positive T-Lymphocytes ; Cell Proliferation ; Combined Modality Therapy ; Gastrointestinal Tract/immunology ; Gastrointestinal Tract/microbiology ; Humans ; Immunity, Innate ; Intestinal Mucosa ; Lymph Nodes ; Macaca mulatta ; Male ; Monocytes ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Acquired Immunodeficiency Syndrome/virology
Czasopismo naukowe
Tytuł:
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
Autorzy:
Verweij MC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Iyer R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
John N; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Scholz I; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Womack J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Abdulhaqq S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Shao J; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Edlefsen PT; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2021 Apr 30; Vol. 372 (6541). Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
CD8-Positive T-Lymphocytes/*immunology
Cytomegalovirus/*metabolism
Genetic Vectors/*metabolism
Histocompatibility Antigens Class I/*metabolism
Peptide Fragments/*metabolism
SAIDS Vaccines/*immunology
Animals ; Cell Line ; Cytomegalovirus/genetics ; Epitopes, T-Lymphocyte/immunology ; Fibroblasts/metabolism ; Genetic Vectors/genetics ; Histocompatibility Antigens Class I/genetics ; Ligands ; Macaca mulatta ; Peptide Fragments/genetics ; Protein Transport ; Simian Immunodeficiency Virus ; HLA-E Antigens
Czasopismo naukowe
Tytuł:
Myelin-specific T cells in animals with Japanese macaque encephalomyelitis.
Autorzy:
Govindan AN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Fitzpatrick KS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Manoharan M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Tagge I; Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, USA.; Montreal Neurological Institute, McGill University, Montreal, QC, USA.
Kohama SG; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, USA.
Ferguson B; Division of Genetics, Oregon National Primate Research Center, Beaverton, OR, USA.
Peterson SM; Division of Genetics, Oregon National Primate Research Center, Beaverton, OR, USA.
Wong GS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Rooney WD; Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, USA.
Park B; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR, USA.
Bourdette DN; Department of Neurology, Multiple Sclerosis Clinic, Oregon Health & Science University, Portland, OR, USA.
Sherman LS; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, USA.; Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
Wong SW; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR, USA.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Feb; Vol. 8 (2), pp. 456-470. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Demyelinating Diseases/*diagnostic imaging
Demyelinating Diseases/*pathology
Encephalomyelitis/*diagnostic imaging
Encephalomyelitis/*pathology
Myelin Sheath/*immunology
T-Lymphocytes/*immunology
Animals ; Autoimmune Diseases/immunology ; Demyelinating Diseases/virology ; Encephalomyelitis/virology ; Enzyme-Linked Immunosorbent Assay ; Epitope Mapping ; Epitopes/genetics ; Epitopes/immunology ; Female ; Herpesviridae Infections/immunology ; Interferon-gamma/analysis ; Interleukin-17/analysis ; Macaca fuscata ; Male ; Monkey Diseases ; Myelin Basic Protein/genetics ; Myelin Basic Protein/immunology ; Myelin Proteolipid Protein/genetics ; Myelin Proteolipid Protein/immunology ; Myelin Sheath/pathology ; Myelin-Oligodendrocyte Glycoprotein/genetics ; Myelin-Oligodendrocyte Glycoprotein/immunology ; Rhadinovirus/genetics ; Rhadinovirus/immunology
Czasopismo naukowe
Tytuł:
In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.
Autorzy:
Taher H; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Mahyari E; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kreklywich C; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Uebelhoer LS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
McArdle MR; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Moström MJ; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Bhusari A; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Nekorchuk M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
E X; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Whitmer T; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Scheef EA; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Sprehe LM; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Roberts DL; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Hughes CM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Jackson KA; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Selseth AN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Cleveland-Rubeor HC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Yue Y; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
Schmidt KA; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
Shao J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Smedley J; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kowalik TF; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Stanton RJ; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Axthelm MK; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Estes JD; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kaur A; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Barry PA; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
Bimber BN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Früh K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Malouli D; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2020 Nov 24; Vol. 16 (11), pp. e1008666. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Viremia*
Cytomegalovirus/*genetics
Cytomegalovirus Infections/*virology
Genome, Viral/*genetics
Animals ; Cell Line ; Chromosomes, Artificial, Bacterial ; Cytomegalovirus/pathogenicity ; DNA, Recombinant ; Disease Models, Animal ; Female ; Fibroblasts/virology ; Humans ; Macaca mulatta ; Male ; Mutation ; Open Reading Frames/genetics ; Phylogeny ; Species Specificity
Czasopismo naukowe
Tytuł:
Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Autorzy:
Wu HL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Weber WC; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Shriver-Munsch C; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Swanson T; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Northrup M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Price H; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Armantrout K; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Robertson-LeVay M; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Reed JS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Bateman KB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Mahyari E; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Thomas A; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Junell SL; Department of Radiation Medicine, Division of Medical Physics, Oregon Health & Science University, Portland, Oregon.
Hobbs TR; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Martin LD; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
MacAllister R; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Bimber BN; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Slifka MK; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Legasse AW; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Moats C; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Axthelm MK; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Smedley J; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Lewis AD; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Colgin L; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Meyers G; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Maziarz RT; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Burwitz BJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Stanton JJ; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Sacha JB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Pokaż więcej
Źródło:
Xenotransplantation [Xenotransplantation] 2020 Jul; Vol. 27 (4), pp. e12578. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:
Disease Models, Animal*
Hematopoietic Stem Cell Transplantation*/adverse effects
Opportunistic Infections*/virology
Virus Diseases*
Allografts ; Animals ; Humans ; Macaca fascicularis
Czasopismo naukowe
Tytuł:
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques.
Autorzy:
Webb GM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Molden J; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Busman-Sahay K; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Abdulhaqq S; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Wu HL; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Weber WC; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Bateman KB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Reed JS; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Northrup M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Maier N; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Tanaka S; ImmunityBio, Los Angeles, California, United States of America.
Gao L; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Davey B; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Carpenter BL; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Axthelm MK; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Stanton JJ; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Smedley J; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Greene JM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Safrit JT; NantKWest, Los Angeles, California, United States of America.
Estes JD; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Skinner PJ; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Sacha JB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2020 Mar 12; Vol. 16 (3), pp. e1008339. Date of Electronic Publication: 2020 Mar 12 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-Retroviral Agents/*administration & dosage
B-Lymphocytes/*drug effects
CD8-Positive T-Lymphocytes/*drug effects
HIV Infections/*drug therapy
Interleukin-15/*antagonists & inhibitors
Killer Cells, Natural/*drug effects
Proteins/*administration & dosage
Animals ; B-Lymphocytes/cytology ; B-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/cytology ; CD8-Positive T-Lymphocytes/immunology ; Cell Movement/drug effects ; Disease Models, Animal ; HIV Infections/genetics ; HIV Infections/immunology ; HIV Infections/physiopathology ; HIV-1/drug effects ; HIV-1/physiology ; Humans ; Interleukin-15/genetics ; Interleukin-15/immunology ; Killer Cells, Natural/cytology ; Killer Cells, Natural/immunology ; Lymph Nodes/drug effects ; Lymph Nodes/immunology ; Macaca mulatta ; Recombinant Fusion Proteins ; Simian Acquired Immunodeficiency Syndrome/drug therapy ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Acquired Immunodeficiency Syndrome/physiopathology ; Simian Acquired Immunodeficiency Syndrome/virology ; Simian Immunodeficiency Virus/drug effects ; Simian Immunodeficiency Virus/physiology ; Virus Latency/drug effects
Czasopismo naukowe
Tytuł:
Molecular analysis of lymphoid tissue from rhesus macaque rhadinovirus-infected monkeys identifies alterations in host genes associated with oncogenesis.
Autorzy:
Estep RD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Govindan AN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Manoharan M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Li H; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Fei SS; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Park BS; Oregon Health & Science University-Portland State University School of Public Health, Portland, Oregon, United States of America.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Wong SW; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Feb 04; Vol. 15 (2), pp. e0228484. Date of Electronic Publication: 2020 Feb 04 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Profiling/*veterinary
Herpesviridae Infections/*veterinary
Rhadinovirus/*pathogenicity
Tumor Virus Infections/*veterinary
Animals ; CX3C Chemokine Receptor 1/genetics ; Cell Transformation, Neoplastic/genetics ; Cytidine Deaminase/genetics ; Gene Expression Regulation, Neoplastic ; Glypicans/genetics ; Herpesviridae Infections/genetics ; Lymphoid Tissue/metabolism ; Macaca mulatta ; Sequence Analysis, RNA/veterinary ; Tumor Virus Infections/genetics ; Virus Latency ; Virus Replication ; ras Proteins/genetics
Czasopismo naukowe
Tytuł:
Characterization of a live-attenuated HCMV-based vaccine platform.
Autorzy:
Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
van den Worm S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Batavia Biosciences B.V., Zernikedreef 16, 2333 CL, Leiden, Netherlands.
Crawford L; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Perez W; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Kreklywich C; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Gilbride RM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Hughes CM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Ratts R; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Vir Biotechnology, 4640, SW Macadam Avenue, Portland, OR, 97239, USA.
Marshall EE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Vir Biotechnology, 4640, SW Macadam Avenue, Portland, OR, 97239, USA.
Malouli D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Streblow D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Nelson JA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA. .
Früh K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Dec 17; Vol. 9 (1), pp. 19236. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytomegalovirus*/genetics
Cytomegalovirus*/immunology
Cytomegalovirus Infections*/genetics
Cytomegalovirus Infections*/immunology
Cytomegalovirus Infections*/prevention & control
Cytomegalovirus Vaccines*/genetics
Cytomegalovirus Vaccines*/immunology
Animals ; Cell Line, Tumor ; Human Umbilical Vein Endothelial Cells ; Humans ; Mice ; Mice, Inbred NOD ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology
Czasopismo naukowe
Tytuł:
Interferon-Gamma test for the detection of Mycobacterium tuberculosis complex infection in Macaca mulatta and other non-human primates.
Autorzy:
Yee JL; California National Primate Research Center, University of California, Davis, California.
Prongay K; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Miles B; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Smedley J; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Hansen SG; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Axthelm MK; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Ardeshir A; California National Primate Research Center, University of California, Davis, California.
Van Rompay KKA; California National Primate Research Center, University of California, Davis, California.
Timmel G; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Roberts JA; California National Primate Research Center, University of California, Davis, California.
Pokaż więcej
Źródło:
Journal of medical primatology [J Med Primatol] 2019 Aug; Vol. 48 (4), pp. 260-263. Date of Electronic Publication: 2019 May 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Macaca mulatta*
Enzyme-Linked Immunosorbent Assay/*veterinary
Interferon-gamma Release Tests/*veterinary
Monkey Diseases/*diagnosis
Mycobacterium tuberculosis/*isolation & purification
Tuberculosis/*diagnosis
Animals ; Enzyme-Linked Immunosorbent Assay/methods ; Interferon-gamma Release Tests/methods
Czasopismo naukowe
Tytuł:
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.
Autorzy:
Hansen SG; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
Womack J; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
Scholz I; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
Renner A; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
Edgel KA; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
Xu G; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
Ford JC; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
Grey M; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
St Laurent B; National Institutes of Health, Laboratory of Malaria and Vector Research, Malaria Pathogenesis and Human Immunity Unit, Rockville, MD, United States of America.
Turner JM; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
Planer S; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
Legasse AW; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
Richie TL; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
Aguiar JC; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
Axthelm MK; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
Villasante ED; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
Weiss W; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Picker LJ; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
Früh K; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jan 23; Vol. 14 (1), pp. e0210252. Date of Electronic Publication: 2019 Jan 23 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Antigens, Protozoan/*immunology
Cytomegalovirus/*genetics
Malaria/*immunology
Malaria Vaccines/*immunology
Parasitemia/*immunology
Plasmodium knowlesi/*immunology
Sporozoites/*immunology
Animals ; Anopheles/immunology ; Anopheles/parasitology ; Female ; Genetic Vectors/administration & dosage ; Immunologic Memory ; Liver/immunology ; Liver/parasitology ; Macaca mulatta ; Malaria/blood ; Malaria/parasitology ; Malaria/prevention & control ; Male ; Parasitemia/blood ; Parasitemia/parasitology ; Parasitemia/prevention & control ; Plasmodium knowlesi/genetics ; Protozoan Proteins/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/parasitology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies